Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation.

Eisenga, Michele F; De Jong, Maarten A; Leaf, David E; Nolte, Ilja M; De Borst, Martin H; Bakker, Stephan J L; Gaillard, Carlo A J M

Eisenga, Michele F; De Jong, Maarten A; Leaf, David E; Nolte, Ilja M; De Borst, Martin H; Bakker, Stephan J L; Gaillard, Carlo A J M.

Afiliação

Eisenga MF; Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
De Jong MA; Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Leaf DE; Division of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
Nolte IM; Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
De Borst MH; Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Bakker SJL; Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Gaillard CAJM; Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.

J Clin Med ; 9(6)2020 06 04.

Article em En | MEDLINE | ID: mdl-32512806

Palavras-chave

death; erythropoietin; fibroblast growth factor 23; kidney transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google